All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for THE HEMOPHILIA ALLIANCE · Nonprofit membership organization for federally-funded hemophilia treatment centers

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 1

JOHANNA GRAY

Previously held: Intern, Senator Barack Obama

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 7

Centers For Medicare and Medicaid Services (CMS)
Federal Trade Commission (FTC)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Labor, Dept of (DOL)
SENATE
Treasury, Dept of

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 6423
HELP Copays Act
HR 247
Health Care Affordability Act of 2025
HR 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
HR 1834
To advance policy priorities that will break the gridlock.

Lobbying activity 4

Medicare/Medicaid

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act

Insurance

H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.

Pharmacy

Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation Polices related to PBMs and drug cost transparency

Budget/Appropriations

Funding for federal hemophilia programs at CDC and HRSA for FY26

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.